BIT 0.00% 2.2¢ biotron limited

Ann: BIT225 TRIAL RESULTS SHOW EFFECTIVE CURE OF HEPATITIS C, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,303 Posts.
    lightbulb Created with Sketch. 1087
    I'm a happy man. This is excellent news for millions of sufferers around the globe.
    BIT225 is set to become a commercial drug and first line treatment for HCV/HIV sufferers.
    Major pharmaceutical companies will be showing a very keen interest in Biotron.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.